"The International Symposium on Cancer Biology" (ISCB), being organised by the National Institute of Immunology (NII) New Delhi in collaboration with Queen's University Belfast was inaugurated at NII. The 3-day Symposium, which ends on November 16, is a part of the University's endeavour to strengthen the links with India in the field of biotechnology. The Symposium brings together world renowned investigators, scientists & oncologist from around the globe. ISCB was inaugurated by Prof. M.K. Bhan, Secy. Department of Biotechnology, Government of India and Sir Reg Empey, Northern Ireland Minister for Employment & Learning. Professor Avadhesha Surolia, Director NII and Professor Patrick Johnston, Queen's University, also graced the occasion. The Conference will be addressed by over 30 speakers from the United States, Europe and India, including seven invitees from the Centre for Cancer Research and Cell Biology at the Queen's University.
Renowned for its record of achievements in frontline research, first class education & a commitment to internationalisation, Queen's University Belfast has signed an agreement with the Department of Biotechnology, Government of India for an international research partnership to develop new ways to treat and understand cancer. Dr Anil Suri, Convener, Cancer Research Program along with top cancer specialists from the National Institute of Immunology, New Delhi and Centre for Cancer Research and Cell Biology, Queen's University has initiated newer approaches to tackle cancer. This joining of forces will create a synergy of knowledge & expertise of Indian & Northern Ireland scientist & doctors in the fight against the deadly menace of cancer.
ISCB proposes to address the therapeutic modalities targeting tumour antigens, tumour immunity, and a careful look at the types of antigens, immunotherapeutic strategies, drug-resistance and the latest clinical trials in major cancer types. Thus, ISCB will provide:
Molecular events regulating cell cycle transitions and their relevance to human cancer, and understanding regulation of cell cycle control through
transcriptional induction of gene expression, protein associations, and post-translational modifications.
Updates on targeted anticancer agents under active development, identification of new molecular targets and their validation and drug discovery and pre-clinical profiles of new-targeted agents.
Cancer Immunology: the players in the immune system, immunity and antigen recognition, human tumours and immunogenicity.
At the inauguration ceremony, Sir Reg Empey, the Northern Ireland Minister for Employment & Learning, said, "NII has great expertise in the diagnosis and treatment of cancer. With the beginning of this new partnership I am confident that we will take significant strides in combating one of the worlds most prevalent diseases."
Commenting on the partnership, Prof. M.K. Bhan, Secy. Deptt. Of Biotechnology, Government of India, said, "NII is a jewel in the crown of this Department. It is the most appropriate vehicle to guide and lead us in our fight against cancer as it is one of the internationally acclaimed pioneering Institutes in the filed of Modern Biology"
Speaking on the occasion, Professor Avadhesha Surolia, Director NII, and a beckon of science in India and a world renowned scientist said, "This joint conference brings together leading biomedical scientists from across the globe concerned with advancing cancer vaccines and immunotherapeutic. The development of new treatments against cancer holds great hope for future patients and this joint conference will provide timely and critical information on how to take an idea from the laboratory to the clinic to the marketplace and demonstrate clearly the benefit of global research partnerships in tackling global problems." He further added that "NII over the last two years has created space for itself by establishing a hub for cancer research program recognised globally".
Leading the Northern Ireland delegation world-renowned cancer oncologist, Professor Patrick Johnston from Queen's University said, "Cancer does not recognise national boundaries and affects people across the globe. It is only through international research partnerships and the sharing of information that we can learn more about the disease. Through this collaboration we will be able to develop new treatments and improve the diagnosis of cancer to the betterment of everyone."
Dr Anil Suri, convener, ISCB, said, "The emphasis should be on detection of the premalignant state of cancer, importance of cancer biomarkers and immunotherapeutic approaches. This symposium will provide the platform for the
world renowned scientists to discuss these issues heralding a new hope for humanity in fight against cancer."
Queen's University India Commitment
The guiding principle of Queen's University is the recognition that knowledge knows no boundaries, and forging of international partnerships is central to the realisation of its Vision for the Future. It has links with universities around the world and is committed to develop & strengthen fruitful partnerships to promote universal welfare. Queen's partnership with India encompasses not only science & medicine but also literature, history, engineering, communication technology & ecology. Queen's commitment to build bridges with Indian academicians & students is reflected in its mutual activities that include: hosting Indian delegations, sending Queen's academic staff to India for fostering and developing research, educational and cultural links every year. Thirdly, there is collaboration with University of Hyderabad which relates to literature, language and translation. There are staff exchanges and student exchanges at undergraduate and postgraduate level with particular emphasis on the impact of English literature on South East Asian writing.
Another is a research partnership, where the emphasis is on Electronic Engineering, Information and Communication Technologies and Environmental Engineering. It also has a partnership on water supply with Shibpur University, Kolkata, which features spilt-site studentships and staff exchanges. Last, but not the least is the QUB-India Lecture Series. This series takes leading scholars and researchers from India to Belfast for public lectures and interactions with relevant Schools within Queen's University, and also brings leading Indian academics from around the globe to an annual symposium that addresses issues of Postcolonial India and Ireland: Empire and Resistance.
Backgrounder
About Queen's University, Belfast
Queen's University Belfast is a member of the prestigious Russell Group of top 20 research-intensive universities in the United Kingdom. Founded in 1845, Queen's has more than 17,000 students from over 80 countries, 3,500 staff and 100,000 graduates worldwide. More than 20 of its courses are cited in The London Times top 20 universities by subject area.
The University is located in Belfast, one of the world's safest cities in which to live and one of the regions in the United Kingdom with the lowest living costs. It hosts the annual internationally acclaimed Belfast Festival and has also hosted the Gandhi, King, Ikeda Peace builders' international Exhibition.
Northern Ireland offers a friendly environment for all its international guests is easily accessible from anywhere in the world and is only one hour by plane from London. The University has a record of achievement in frontline research, first-class education and a commitment to internationalization. Queen's is currently investing over $500 million in its staff, students and infrastructure to develop a community of world-class academics and students.
About The National Institute of Immunology
The National Institute of Immunology (NII) is an autonomous institution supported by the Department of Biotechnology, Government of India. The Institute is committed to advanced research addressing the basic mechanisms involved in body defence, host-pathogen interactions and related areas with a view to contribute to the creation of an internationally competitive intellectual knowledge base as a sustainable source of innovative futuristic modalities of potential use in health care. To this end, the Institute follows a two-pronged strategy of linking excellence in rigorous fundamental research with the pragmatic pursuit of emerging application possibilities in entrepreneurial partnerships.
Over thirty independent research groups work in a broad range of modern biological disciplines at NII in dissecting the molecular mechanisms of interaction between the biological systems and their environment. The research interests of the current groups coalesce in four major areas; Gene Regulation, Immunity & Infection, Molecular Design, and Reproduction & Development. The Institute also attempts to contribute to the enhancement of national research competence in the life sciences by providing advanced interdisciplinary teaching and training, including a doctoral programme in academic affiliation with the Jawaharlal Nehru University, New Delhi.
National Institute of Immunology
Комментариев нет:
Отправить комментарий